India  

Moderna COVID-19 Vaccine Approved for Use in the European Union

Video Credit: Wibbitz Top Stories - Duration: 01:07s - Published
Moderna COVID-19 Vaccine Approved for Use in the European Union

Moderna COVID-19 Vaccine Approved for Use in the European Union

Moderna COVID-19 Vaccine Approved for Use in the European Union.

It is the second vaccine to be green-lit by regulators in Europe.

Following the Pfizer-BioNTech COVID-19 vaccine.

The European Commission authorized the vaccine on Wednesday following a recommendation from the European Medicines Agency (EMA).

The EMA made its recommendation earlier that day, saying it had “thoroughly assessed the data” and passed it on to the European Commission.

.

EMA’s human medicines committee has thoroughly assessed the data on the quality, safety and efficacy of the vaccine and recommended by consensus a formal conditional marketing authorization be granted by the European Commission, EMA, via CNBC.

In a statement, the president of the European Commission, Ursula von der Leyen, said the EU would gain an additional 160 million doses with “more vaccines [to] come.” .

Europe has secured up to two billion doses of potential COVID-19 vaccines … We’ll have more than enough safe and effective vaccines for protecting all Europeans, Ursula von der Leyen, via CNBC


You Might Like


Related videos from verified sources

EU vaccine row: Gove 'confident' programme will continue as planned [Video]

EU vaccine row: Gove 'confident' programme will continue as planned

Cabinet Office minister Michael Gove said the Government expects coronavirus vaccines manufactured by Pfizer and AstraZeneca to be supplied to the UK, after a discussion with the EU chief.He told..

Credit: PA - Press Association STUDIO     Duration: 01:49Published
Daily politics briefing: January 30 [Video]

Daily politics briefing: January 30

A look at the key figures and dates in the world of politics on January 30, as the EU reverses its decision to override part of the Brexit deal amid an ongoing row over Covid vaccine supplies in the..

Credit: PA - Press Association STUDIO     Duration: 00:47Published
J&J COVID-19 vaccine 66% effective globally [Video]

J&J COVID-19 vaccine 66% effective globally

Johnson & Johnson announced Friday that its single-dose vaccine was 66% effective globally in preventing COVID-19, and 72% effective in the United States. The company plans to seek emergency use..

Credit: Reuters Studio     Duration: 02:08Published